Start or STop Anticoagulants Randomised Trial (SoSTART)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 203 participants.

Also called NCT03153150

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 203 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03153150
  • EudraCT 2016-004121-16
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03153150. Randomized; single masking; primary purpose prevention. Start 2018-03-28 (actual); primary completion 2021-03-26 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Start or STop Anticoagulants Randomised Trial (SoSTART)
Acronym
SoSTART
Condition
Intracranial Hemorrhages
Condition
Intracranial Hemorrhage, Hypertensive
Condition
Subarachnoid Hemorrhage
Condition
Subdural Hematoma
Condition
Intraventricular Hemorrhage
Condition
Small Vessel Cerebrovascular Disease
Condition
Microhaemorrhage
Intervention (Drug)
Apixaban
Intervention (Drug)
Rivaroxaban
Intervention (Drug)
Edoxaban
Intervention (Drug)
Dabigatran
Intervention (Drug)
Acenocoumarol
Intervention (Drug)
Phenindione
Intervention (Drug)
Warfarin
Lead sponsor
University of Edinburgh (class: other)
Collaborator
NHS Lothian (class: other government)

Record details

Record id
cardio:ct-nct03153150
Content hash
27aaf1b08026b96bc5ca345a3489a2b5d381093228cd35dbec1ee4f68f8494ac